Breaking News
1. Rouse Avenue Court extends judicial custody of Manish Sisodia and other accused till July 26      2. Supreme Court hearing NEET-UG issue      3. Singer Rahat Fateh Ali Khan arrested in Dubai: Reports      4. Assam CM Himanta Biswa Sarma meets PM Narendra Modi in Delhi      5. India needs to strike balance between import of goods and FDI inflows from China: CEA      6. INDIA bloc to convene meeting tomorrow      7. India's forex reserves surge to record high of $666.85 billion as of July 12      8. Hatred is in the veins of BJP: AAP MP Sanjay Singh      9. Union Home Minister Amit Shah chairs high level meeting with various Heads of Security and Law Enforcement Agencies      10. UP Vidhan Sabha session will begin from July 29      11. Indrani Mukerjea allowed 10-day abroad travel by special CBI court in Mumbai      12. Andhra Pradesh: Union Minister Nitin Gadkari visits Tirumala Venkateshwara Temple in Tirupati      13. Encounter breaks out in J-K's Doda      14. Moderate to heavy rain is expected in Mumbai, its suburbs today      15. Karnataka: Truck and tanker drivers stranded in Akola's Shirur due to landslide      16. Heavy rainfall triggers waterlogging in Mumbai      17. Navdeep Singh farmer activist walks out of jail after getting bail      18. NCB arrests man wanted in Rs 60 crore mephedrone seizure case      19. PM Modi likely to visit BJP headquarters on Thursday, to address party workers: Report      20. Union Cabinet to meet tomorrow, 18th July at 10:30 AM: Report     

Abortion Pills Still Available in Market with Strict Regulations: US Court on Mifepristone's Sale

  • Posted on April 13, 2023
  • News

 A US Federal Court has ruled to continue with the sale of abortion drugs for the time being but has imposed stricter regulations regarding their disposal. Coming during the recognition of privacy rights of women undergoing legal abortion, this ruling becomes particularly significant, here is why.


 Mifepristone, an abortion drug in combination with Misoprostol, was given a green flag by the Food and Drug Administration of the U.S. The case is now likely to be forwarded to the Supreme Court of the U.S. after the Wednesday (April 12, 2023) judgement of 5th US Circuit Court of Appeals, New Orleans.


The initial ruling by a judge of a lower court in Texas adjudged the recognition of the drug provided by FDA to be reversed, in a suit brought by competitors of Mifepristone. The decision has now been overturned by a three judge bench with 2-1 vote.


Awaiting an appeal, the Texas court judgement had been paused for a week.

The appellate court has upheld the validity of FDAs recognition of Mifepristone in 2000, overruling the judgement of the lower court.


The validity though has been contended to include tougher regulations as against the relaxation provided by FDA in 2016. The relaxations included elongated pregnancy period for administration of drug along with provision to send it on mail without requiring doctor consultation.


The propaganda seekers relate the actions of the two judges, Kurt Engelhardt and Andrew Oldham, in the opinion of stricter regulations to former president Trump's ideologies as they were appointed during his tenure. Judge Catharina Haynes liberal say in matter opining the put the lower court's judgement completely on hold for oral arguments is reasoned with her being appointed by former president George W. Bush.


Mifepristone, a drug has been in use since two decades and is known to have very mild complications in women even lower than various routine treatments as per medical groups.


For more updates keep visiting our website where we provide unbiased, true, and top stories of the world.

No Image

You May Also Like